Literature DB >> 29793180

Insulin is a potential antioxidant for diabetes-associated cognitive decline via regulating Nrf2 dependent antioxidant enzymes.

Ying Song1, Wei Ding2, Yun Bei3, Yan Xiao4, Hai-Da Tong5, Li-Bo Wang6, Li-Yao Ai6.   

Abstract

PURPOSE: To investigate the neuroprotective effects of insulin on diabetic encephalopathy and its mechanism. EXPERIMENTAL AND APPROACH: The diabetic model was established by injection of streptozotocin. Behavior examinations were conducted by the Morris water maze. Histopathological alterations were detected by HE staining. ROS, CAT levels and SOD activity were measured using a microplate reader. In vitro, the viability of wild type and knock-down PC12 cells was detected by MTT assay, the morphology of cells was monitored under a microscope. The subcellular distribution of Nrf2 was observed by western blotting and immunohistochemistry. KEY
RESULTS: Evident oxidative stress injury was observed in diabetic rats and H2O2-induced PC12 cells. Insulin not only protect diabetic rat from oxidative stress injury but also significantly inhibited H2O2-induced apoptosis and intracellular ROS in cells. In addition, the level of malondialdehyde was reduced, and the activities of superoxide dismutase, catalase and glutathione peroxidase were augmented in both diabetic rats and PC12 cells. Interestingly, insulin promoted the translocation of Nrf2 into the nucleus and activation of downstream antioxidant protein expression. Further, the Nrf2 knockdown cells suffered more serious H2O2-induced damage than the wild PC12 cells. Moreover, insulin had no significant protective effect on knockdown cells with H2O2-damage. CONCLUSION AND IMPLICATIONS: Collectively, our results suggested that insulin significantly inhibited neuronal damage through the Nrf2 signaling pathway, which regulates endogenous oxidant-antioxidant balance, therefore, insulin may be a potential protective agent for the treatment of oxidative stress-induced diabetic encephalopathy.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antoxidant; Diabetic encephalopathy; Insulin; NF-E2-related factor 2; Oxidative stress; Rat pheochromocytoma

Mesh:

Substances:

Year:  2018        PMID: 29793180     DOI: 10.1016/j.biopha.2018.04.097

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  DL-3-n-butylphthalide ameliorates diabetes-associated cognitive decline by enhancing PI3K/Akt signaling and suppressing oxidative stress.

Authors:  Bei-Ni Wang; Cheng-Biao Wu; Zi-Miao Chen; Pei-Pei Zheng; Ya-Qian Liu; Jun Xiong; Jing-Yu Xu; Pei-Feng Li; Abdullah Al Mamun; Li-Bing Ye; Zhi-Long Zheng; Yan-Qing Wu; Jian Xiao; Jian Wang
Journal:  Acta Pharmacol Sin       Date:  2021-01-18       Impact factor: 6.150

Review 2.  Insulin Signaling Impairment in the Brain as a Risk Factor in Alzheimer's Disease.

Authors:  Christian Hölscher
Journal:  Front Aging Neurosci       Date:  2019-04-24       Impact factor: 5.750

Review 3.  The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease.

Authors:  Shengnan Shen; Qiwen Liao; Yin Kwan Wong; Xiao Chen; Chuanbin Yang; Chengchao Xu; Jichao Sun; Jigang Wang
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 4.  Recent Advances in Understanding Nrf2 Agonism and Its Potential Clinical Application to Metabolic and Inflammatory Diseases.

Authors:  Min-Ji Kim; Jae-Han Jeon
Journal:  Int J Mol Sci       Date:  2022-03-05       Impact factor: 5.923

Review 5.  New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors.

Authors:  Prabhakar Busa; Yaswanth Kuthati; Niancih Huang; Chih-Shung Wong
Journal:  Front Pharmacol       Date:  2022-04-12       Impact factor: 5.988

6.  Facilitation of Insulin Effects by Ranolazine in Astrocytes in Primary Culture.

Authors:  Adrián Jordá; Martin Aldasoro; Ignacio Campo-Palacio; Jose M Vila; Constanza Aldasoro; Juan Campos-Campos; Carlos Colmena; Sandeep Kumar Singh; Elena Obrdor; Soraya L Valles
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.